New drug cocktail aims to reset gulf war illness symptoms
NCT ID NCT04254627
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a combination of two drugs (etanercept and mifepristone) in 20 male veterans with Gulf War Illness. The goal was to see if the treatment is safe and can help reset the body's systems to reduce symptoms like fatigue, pain, and memory problems. Results will guide future larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GULF WAR ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Miami VA Healthcare System
Miami, Florida, 33125, United States
-
Nova Southeastern University
Davie, Florida, 33314, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gulf war Veterans' brain blood flow under the microscope
- New care model aims to help gulf war vets get the treatment they deserve
- Could a potato starch supplement ease gulf war illness?
- Electric zaps to the brain may help veterans remember words
- AI tailors brain zaps to ease Veterans' gulf war pain
- Can kitchen spices soothe gulf war illness? new trial seeks answers